<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cancers | BM Sci-Tech Memento</title>
    <link>https://example.com/tag/cancers/</link>
      <atom:link href="https://example.com/tag/cancers/index.xml" rel="self" type="application/rss+xml" />
    <description>Cancers</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Mon, 02 Jan 2023 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://example.com/media/icon_hu1efa9af2edf414d45fb59503b457ea16_13437_512x512_fill_lanczos_center_3.png</url>
      <title>Cancers</title>
      <link>https://example.com/tag/cancers/</link>
    </image>
    
    <item>
      <title>Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma</title>
      <link>https://example.com/article/23-01-03-08-19/</link>
      <pubDate>Mon, 02 Jan 2023 00:00:00 +0000</pubDate>
      <guid>https://example.com/article/23-01-03-08-19/</guid>
      <description>&lt;p&gt;&lt;strong&gt;Abstract&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Enhanced glycolysis and accumulation of lactate is a common feature in various types of cancer. Intracellular lactate drives a recently described type of posttranslational modification, lysine lactylation (Kla), on core histones. However, the impact of lactylation on biological processes of tumour cells remains largely unknown. Here we show a global lactylome profiling on a prospectively collected hepatitis B virus-related hepatocellular carcinoma (HCC) cohort. Integrative lactylome and proteome analysis of the tumours and adjacent livers identifies 9,275 Kla sites, with 9,256 sites on non-histone proteins, indicating that Kla is a prevalent modification beyond histone proteins and transcriptional regulation. Notably, Kla preferentially affects enzymes involved in metabolic pathways, including the tricarboxylic acid cycle, and carbohydrate, amino acid, fatty acid and nucleotide metabolism. We further verify that lactylation at K28 inhibits the function of adenylate kinase 2, facilitating the proliferation and metastasis of HCC cells. Our study therefore reveals that Kla plays an important role in regulating cellular metabolism and may contribute to HCC progression.&lt;/p&gt;
&lt;ul class=&#34;cta-group&#34;&gt;
  
  &lt;li&gt;
    &lt;a href=&#34;https://example.com/article/&#34;  class=&#34;btn btn-primary px-3 py-3&#34;&gt;&lt;font color=&#39;white&#39;&gt; &amp;lt; Back to Articles &lt;/font&gt;&lt;/a&gt;
  &lt;/li&gt;
  
  
  &lt;li&gt;
    &lt;a href=&#34;https://example.com/&#34; &gt;
      Alternative to Homepage &lt;i class=&#34;fas fa-angle-right&#34;&gt;&lt;/i&gt;
    &lt;/a&gt;
  &lt;/li&gt;
  
&lt;/ul&gt;

</description>
    </item>
    
    <item>
      <title>Comprehensive databases for biomedical research</title>
      <link>https://example.com/tool/db-biomed-res/</link>
      <pubDate>Wed, 02 Dec 2020 00:00:00 +0000</pubDate>
      <guid>https://example.com/tool/db-biomed-res/</guid>
      <description>&lt;ul&gt;
&lt;li&gt;&lt;a href=&#34;https://db.cngb.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;strong&gt;China National GeneBank DataBase (CNGBdb)&lt;/strong&gt;&lt;/a&gt; is a uniÔ¨Åed platform built for biological big data sharing and application services to the research community. Based on the big data and cloud computing technologies, it provides data services such as archive, analysis, knowledge search, management authorization, and visualization.&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://www.ncbi.nlm.nih.gov/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;strong&gt;National Center for Biotechnology Information (NCBI)&lt;/strong&gt;&lt;/a&gt; advances science and health by providing access to biomedical and genomic information.
&lt;ul&gt;
&lt;li&gt;&lt;a href=&#34;https://pubmed.ncbi.nlm.nih.gov/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;PubMed&lt;/em&gt;&lt;/a&gt; comprises more than 34 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full text content from PubMed Central and publisher web sites.&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://www.ncbi.nlm.nih.gov/gene/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;Gene&lt;/em&gt;&lt;/a&gt; supplies gene-specific connections in the nexus of map, sequence, expression, structure, function, citation, and homology data. Unique identifiers are assigned to genes with defining sequences, genes with known map positions, and genes inferred from phenotypic information.&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://www.ncbi.nlm.nih.gov/nuccore/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;Nucleotide&lt;/em&gt;&lt;/a&gt; deposites DNA and RNA sequences.&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://www.ncbi.nlm.nih.gov/geo/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;Gene Expression Omnibus (GEO)&lt;/em&gt;&lt;/a&gt;  is a public functional genomics data repository supporting MIAME-compliant data submissions. Array- and sequence-based data are accepted. Tools are provided to help users query and download experiments and curated gene expression profiles. Users can also analyze published data to identify genes that are differentially expressed across experimental conditions with &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/geo/geo2r/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;GEO2R&lt;/a&gt;, where codes and scripts are not needed.&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://blast.ncbi.nlm.nih.gov/Blast.cgi&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;Basic Local Alignment Search Tool (BLAST)&lt;/em&gt;&lt;/a&gt; finds regions of similarity between biological sequences. The program compares nucleotide or protein sequences to sequence databases and calculates the statistical significance.&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://www.ebi.ac.uk/biostudies/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;strong&gt;BioStudies&lt;/strong&gt;&lt;/a&gt; holds descriptions of biological studies, links to data from these studies in other databases at &lt;a href=&#34;https://www.ebi.ac.uk/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;EMBL-EBI&lt;/a&gt; or outside, as well as data that do not fit in the structured archives at &lt;a href=&#34;https://www.ebi.ac.uk/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;EMBL-EBI&lt;/a&gt;. The database accepts submissions via an online tool, or in a simple tab-delimited format. It also enables authors to submit supplementary information and link to it from the publication.
&lt;ul&gt;
&lt;li&gt;&lt;a href=&#34;https://www.ebi.ac.uk/biostudies/arrayexpress&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;ArrayExpress&lt;/em&gt;&lt;/a&gt;, the functional genomics collection, stores data from high-throughput functional genomics experiments, and provides data for reuse to the research community. In line with community guidelines, a study typically contains metadata such as detailed sample annotations, protocols, processed data and raw data. Raw sequence reads from high-throughput sequencing studies are brokered to the European Nucleotide Archive (ENA), and links are provided to download the sequence reads from ENA. Data can be submitted to the &lt;a href=&#34;https://www.ebi.ac.uk/biostudies/arrayexpress&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;ArrayExpress&lt;/em&gt;&lt;/a&gt; collection through its dedicated submission tool, Annotare.&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Genomes&lt;/strong&gt;
&lt;ul&gt;
&lt;li&gt;&lt;a href=&#34;https://www.ensembl.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;Ensembl&lt;/em&gt;&lt;/a&gt; is a genome browser for vertebrate genomes that supports research in comparative genomics, evolution, sequence variation and transcriptional regulation and a part of the &lt;a href=&#34;https://elixir-europe.org/platforms/data/core-data-resources&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;ELIXIR Core Data Resources&lt;/a&gt;.&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;http://www.genome.ucsc.edu/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;The UCSC Genome Browser&lt;/em&gt;&lt;/a&gt; is a web-based tool serving as a multi-powered microscope that allows researchers to view all 23 chromosomes of the human genome at any scale from a full chromosome down to an individual nucleotide.&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://www.gencodegenes.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;GENCODE&lt;/em&gt;&lt;/a&gt; aims to identify and classify all gene features in the human and mouse genomes with high accuracy based on biological evidence, and to release these annotations for the benefit of biomedical research and genome interpretation.&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;http://www.noncode.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;NONCODE&lt;/em&gt;&lt;/a&gt; is an integrated knowledge database dedicated to non-coding RNAs (excluding tRNAs and rRNAs). The source of &lt;a href=&#34;http://www.noncode.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;NONCODE&lt;/em&gt;&lt;/a&gt; includes literature and other public databases. &lt;a href=&#34;http://www.noncode.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;NONCODE&lt;/em&gt;&lt;/a&gt; searches PubMed using key words &lt;code&gt;ncrna&lt;/code&gt;, &lt;code&gt;noncoding&lt;/code&gt;, &lt;code&gt;non-coding&lt;/code&gt;, &lt;code&gt;no code&lt;/code&gt;, &lt;code&gt;non-code&lt;/code&gt;, &lt;code&gt;lncrna&lt;/code&gt; or &lt;code&gt;lincrna&lt;/code&gt;. NONCODE retrieves the new identified lncRNAs and their annotation from the Supplementary Material or web site of these articles. Together with the newest data from &lt;a href=&#34;https://www.ensembl.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Ensembl&lt;/a&gt;, &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/refseq/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;RefSeq&lt;/a&gt;, &lt;a href=&#34;http://lncrnadb.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;lncRNAdb&lt;/a&gt; and &lt;a href=&#34;https://www.gencodegenes.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;GENCODE&lt;/a&gt; were processed through a standard pipeline for each species.&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://www.encodeproject.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;Encyclopedia of DNA Elements (ENCODE)&lt;/em&gt;&lt;/a&gt; Consortium is an ongoing international collaboration of research groups funded by the National Human Genome Research Institute (NHGRI). The goal of &lt;a href=&#34;https://www.encodeproject.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;ENCODE&lt;/em&gt;&lt;/a&gt; is to build a comprehensive parts list of functional elements in the human genome, including elements that act at the protein and RNA levels, and regulatory elements that control cells and circumstances in which a gene is active.&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Cancers&lt;/strong&gt;
&lt;ul&gt;
&lt;li&gt;&lt;a href=&#34;https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;The Cancer Genome Atlas (TCGA)&lt;/em&gt;&lt;/a&gt;, a landmark cancer genomics program, molecularly characterizes over 20,000 primary cancer and matched normal samples spanning 33 cancer types. Usually, we prefer to access the Database via &lt;a href=&#34;https://portal.gdc.cancer.gov/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Genomic Data Commons Data Portal (GDC)&lt;/a&gt;.&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://www.cbioportal.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;cBioPortal&lt;/em&gt;&lt;/a&gt; for Cancer Genomics was originally developed at &lt;a href=&#34;https://www.mskcc.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Memorial Sloan Kettering Cancer Center (MSKCC)&lt;/a&gt;. The public &lt;a href=&#34;https://www.cbioportal.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;cBioPortal&lt;/em&gt;&lt;/a&gt; site is hosted by the Center for &lt;a href=&#34;https://www.mskcc.org/research-programs/molecular-oncology&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Molecular Oncology&lt;/a&gt; at &lt;a href=&#34;https://www.mskcc.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;MSKCC&lt;/a&gt;. The &lt;a href=&#34;https://www.cbioportal.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;cBioPortal&lt;/em&gt;&lt;/a&gt; software is now available under an open source license via &lt;a href=&#34;https://github.com/cBioPortal/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;GitHub&lt;/a&gt; 
  &lt;i class=&#34;fab fa-github  pr-1 fa-fw&#34;&gt;&lt;/i&gt;.&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;http://gepia2.cancer-pku.cn/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;GEPIA&lt;/em&gt;&lt;/a&gt; is for analyzing the RNA sequencing expression data of 9,736 tumors and 8,587 normal samples from the &lt;a href=&#34;https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;TCGA&lt;/a&gt; and the &lt;a href=&#34;https://www.gtexportal.org/home&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;GTEx&lt;/a&gt; projects, using a standard processing pipeline. &lt;a href=&#34;http://gepia2.cancer-pku.cn/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;GEPIA&lt;/em&gt;&lt;/a&gt; provides customizable functions such as tumor/normal differential expression analysis, profiling according to cancer types or pathological stages, patient survival analysis, similar gene detection, correlation analysis and dimensionality reduction analysis.&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;http://xena.ucsc.edu/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;UCSC Xena&lt;/em&gt;&lt;/a&gt; allows users to explore functional genomic data sets for correlations between genomic and/or phenotypic variables. It provides interactive online visualization of seminal cancer genomics datasets, including data from &lt;a href=&#34;https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;(TCGA)&lt;/a&gt;, &lt;a href=&#34;https://dcc.icgc.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;International Cancer Genome Consortium (ICGC)&lt;/a&gt;, and &lt;a href=&#34;https://gdc.cancer.gov/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Genomic Data Commons (GDC)&lt;/a&gt;. &lt;a href=&#34;http://xena.ucsc.edu/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;UCSC Xena&lt;/em&gt;&lt;/a&gt; also visualizes the UCSC RNA-seq compendium which contains data from &lt;a href=&#34;https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;TCGA&lt;/a&gt; tumor samples, &lt;a href=&#34;https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;TCGA&lt;/a&gt; normal samples, and &lt;a href=&#34;https://www.gtexportal.org/home&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;GTEx&lt;/a&gt; normal samples. &lt;a href=&#34;http://xena.ucsc.edu/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;UCSC Xena&lt;/em&gt;&lt;/a&gt; supports virtually any functional genomics data, including SNVs, INDELs, large structural variants, copy number variation, gene-, transcript-, exon-, miRNA-, LncRNA-, protein-expressions, DNA methylation, ATAC-seq signals, phenotypic/clinical annotations, and higher-level derived genomic parameters.&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://gdac.broadinstitute.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;Broad GDAC&lt;/em&gt;&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;ul class=&#34;cta-group&#34;&gt;
  
  &lt;li&gt;
    &lt;a href=&#34;https://example.com/tag/databases/&#34;  class=&#34;btn btn-primary px-3 py-3&#34;&gt;&lt;font color=&#39;white&#39;&gt; &amp;lt; Back to Databases&lt;/font&gt;&lt;/a&gt;
  &lt;/li&gt;
  
  
  &lt;li&gt;
    &lt;a href=&#34;https://example.com/tool/&#34; &gt;
      Alternative to Tools &lt;i class=&#34;fas fa-angle-right&#34;&gt;&lt;/i&gt;
    &lt;/a&gt;
  &lt;/li&gt;
  
&lt;/ul&gt;

</description>
    </item>
    
    <item>
      <title>Databases make cancer research easier</title>
      <link>https://example.com/tool/2020-02-22-dtb-cancer-res/</link>
      <pubDate>Sat, 22 Feb 2020 00:00:00 +0000</pubDate>
      <guid>https://example.com/tool/2020-02-22-dtb-cancer-res/</guid>
      <description>&lt;ul&gt;
&lt;li&gt;
&lt;p&gt;&lt;a href=&#34;https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;The Cancer Genome Atlas (TCGA)&lt;/em&gt;&lt;/a&gt;, a landmark cancer genomics program, molecularly characterizes over 20,000 primary cancer and matched normal samples spanning 33 cancer types. Usually, we prefer to access the Database via &lt;a href=&#34;https://portal.gdc.cancer.gov/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Genomic Data Commons Data Portal (GDC)&lt;/a&gt;.&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;&lt;a href=&#34;https://www.cbioportal.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;cBioPortal&lt;/em&gt;&lt;/a&gt; for Cancer Genomics was originally developed at &lt;a href=&#34;https://www.mskcc.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Memorial Sloan Kettering Cancer Center (MSKCC)&lt;/a&gt;. The public &lt;a href=&#34;https://www.cbioportal.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;cBioPortal&lt;/em&gt;&lt;/a&gt; site is hosted by the Center for &lt;a href=&#34;https://www.mskcc.org/research-programs/molecular-oncology&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Molecular Oncology&lt;/a&gt; at &lt;a href=&#34;https://www.mskcc.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;MSKCC&lt;/a&gt;. The &lt;a href=&#34;https://www.cbioportal.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;cBioPortal&lt;/em&gt;&lt;/a&gt; software is now available under an open source license via &lt;a href=&#34;https://github.com/cBioPortal/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;GitHub&lt;/a&gt; 
  &lt;i class=&#34;fab fa-github  pr-1 fa-fw&#34;&gt;&lt;/i&gt;.&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;&lt;a href=&#34;http://gepia2.cancer-pku.cn/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;GEPIA&lt;/em&gt;&lt;/a&gt; is for analyzing the RNA sequencing expression data of 9,736 tumors and 8,587 normal samples from the &lt;a href=&#34;https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;TCGA&lt;/a&gt; and the &lt;a href=&#34;https://www.gtexportal.org/home&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;GTEx&lt;/a&gt; projects, using a standard processing pipeline. &lt;a href=&#34;http://gepia2.cancer-pku.cn/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;GEPIA&lt;/em&gt;&lt;/a&gt; provides customizable functions such as tumor/normal differential expression analysis, profiling according to cancer types or pathological stages, patient survival analysis, similar gene detection, correlation analysis and dimensionality reduction analysis.&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;&lt;a href=&#34;http://xena.ucsc.edu/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;UCSC Xena&lt;/em&gt;&lt;/a&gt; allows users to explore functional genomic data sets for correlations between genomic and/or phenotypic variables. It provides interactive online visualization of seminal cancer genomics datasets, including data from &lt;a href=&#34;https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;(TCGA)&lt;/a&gt;, &lt;a href=&#34;https://dcc.icgc.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;International Cancer Genome Consortium (ICGC)&lt;/a&gt;, and &lt;a href=&#34;https://gdc.cancer.gov/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Genomic Data Commons (GDC)&lt;/a&gt;. &lt;a href=&#34;http://xena.ucsc.edu/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;UCSC Xena&lt;/em&gt;&lt;/a&gt; also visualizes the UCSC RNA-seq compendium which contains data from &lt;a href=&#34;https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;TCGA&lt;/a&gt; tumor samples, &lt;a href=&#34;https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;TCGA&lt;/a&gt; normal samples, and &lt;a href=&#34;https://www.gtexportal.org/home&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;GTEx&lt;/a&gt; normal samples. &lt;a href=&#34;http://xena.ucsc.edu/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;UCSC Xena&lt;/em&gt;&lt;/a&gt; supports virtually any functional genomics data, including SNVs, INDELs, large structural variants, copy number variation, gene-, transcript-, exon-, miRNA-, LncRNA-, protein-expressions, DNA methylation, ATAC-seq signals, phenotypic/clinical annotations, and higher-level derived genomic parameters.&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;&lt;a href=&#34;https://gdac.broadinstitute.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;em&gt;Broad GDAC&lt;/em&gt;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;ul class=&#34;cta-group&#34;&gt;
  
  &lt;li&gt;
    &lt;a href=&#34;https://example.com/tag/databases/&#34;  class=&#34;btn btn-primary px-3 py-3&#34;&gt;&lt;font color=&#39;white&#39;&gt; &amp;lt; Back to Databases&lt;/font&gt;&lt;/a&gt;
  &lt;/li&gt;
  
  
  &lt;li&gt;
    &lt;a href=&#34;https://example.com/tool/&#34; &gt;
      Alternative to Tools &lt;i class=&#34;fas fa-angle-right&#34;&gt;&lt;/i&gt;
    &lt;/a&gt;
  &lt;/li&gt;
  
&lt;/ul&gt;

</description>
    </item>
    
    <item>
      <title>An oncolytic herpesvirus expressing E-cadherin improves survival in mouse models of glioblastoma</title>
      <link>https://example.com/article/30475349/</link>
      <pubDate>Mon, 26 Nov 2018 00:00:00 +0000</pubDate>
      <guid>https://example.com/article/30475349/</guid>
      <description>&lt;p&gt;&lt;strong&gt;Abstract&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The efficacy of oncolytic herpes simplex virus (oHSV) is limited by rapid viral clearance by innate immune effector cells and poor intratumoral viral spread. We combine two approaches to overcome these barriers: inhibition of natural killer (NK) cells and enhancement of intratumoral viral spread. We engineered an oHSV to express CDH1, encoding E-cadherin, an adherent molecule and a ligand for KLRG1, an inhibitory receptor expressed on NK cells. In vitro, infection with this engineered virus, named OV-CDH1, induced high surface E-cadherin expression on infected glioblastoma (GBM) cells, which typically lack endogenous E-cadherin. Ectopically expressed E-cadherin enhanced the spread of OV-CDH1 by facilitating cell-to-cell infection and viral entry and reduced viral clearance by selectively protecting OV-CDH1-infected cells from KLRG1+ NK cell killing. In vivo, OV-CDH1 treatment substantially prolonged the survival in GBM-bearing mouse models, primarily because of improved viral spread rather than inhibition of NK cell activity. Thus, virus-induced overexpression of E-cadherin may be a generalizable strategy for improving cancer virotherapy.&lt;/p&gt;
&lt;ul class=&#34;cta-group&#34;&gt;
  
  &lt;li&gt;
    &lt;a href=&#34;https://example.com/article/&#34;  class=&#34;btn btn-primary px-3 py-3&#34;&gt;&lt;font color=&#39;white&#39;&gt; &amp;lt; Back to Articles &lt;/font&gt;&lt;/a&gt;
  &lt;/li&gt;
  
  
  &lt;li&gt;
    &lt;a href=&#34;https://example.com/&#34; &gt;
      Alternative to Homepage &lt;i class=&#34;fas fa-angle-right&#34;&gt;&lt;/i&gt;
    &lt;/a&gt;
  &lt;/li&gt;
  
&lt;/ul&gt;

</description>
    </item>
    
    <item>
      <title>Homeobox oncogene activation by pan-cancer DNA hypermethylation</title>
      <link>https://example.com/article/30097071/</link>
      <pubDate>Fri, 10 Aug 2018 00:00:00 +0000</pubDate>
      <guid>https://example.com/article/30097071/</guid>
      <description>&lt;p&gt;&lt;strong&gt;Abstract&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;em&gt;Background:&lt;/em&gt; Cancers have long been recognized to be not only genetically but also epigenetically distinct from their tissues of origin. Although genetic alterations underlying oncogene upregulation have been well studied, to what extent epigenetic mechanisms, such as DNA methylation, can also induce oncogene expression remains unknown.&lt;/p&gt;
&lt;p&gt;&lt;em&gt;Results:&lt;/em&gt; Here, through pan-cancer analysis of 4174 genome-wide profiles, including whole-genome bisulfite sequencing data from 30 normal tissues and 35 solid tumors, we discover a strong correlation between gene-body hypermethylation of DNA methylation canyons, defined as broad under-methylated regions, and overexpression of approximately 43% of homeobox genes, many of which are also oncogenes. To gain insights into the cause-and-effect relationship, we use a newly developed dCas9-SunTag-DNMT3A system to methylate genomic sites of interest. The locus-specific hypermethylation of gene-body canyon, but not promoter, of homeobox oncogene DLX1, can directly increase its gene expression.&lt;/p&gt;
&lt;p&gt;&lt;em&gt;Conclusions:&lt;/em&gt; Our pan-cancer analysis followed by functional validation reveals DNA hypermethylation as a novel epigenetic mechanism for homeobox oncogene upregulation.&lt;/p&gt;
&lt;ul class=&#34;cta-group&#34;&gt;
  
  &lt;li&gt;
    &lt;a href=&#34;https://example.com/article/&#34;  class=&#34;btn btn-primary px-3 py-3&#34;&gt;&lt;font color=&#39;white&#39;&gt; &amp;lt; Back to Articles &lt;/font&gt;&lt;/a&gt;
  &lt;/li&gt;
  
  
  &lt;li&gt;
    &lt;a href=&#34;https://example.com/&#34; &gt;
      Alternative to Homepage &lt;i class=&#34;fas fa-angle-right&#34;&gt;&lt;/i&gt;
    &lt;/a&gt;
  &lt;/li&gt;
  
&lt;/ul&gt;

</description>
    </item>
    
    <item>
      <title>Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing</title>
      <link>https://example.com/article/28622514/</link>
      <pubDate>Thu, 15 Jun 2017 00:00:00 +0000</pubDate>
      <guid>https://example.com/article/28622514/</guid>
      <description>&lt;p&gt;&lt;strong&gt;Abstract&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Systematic interrogation of tumor-infiltrating lymphocytes is key to the development of immunotherapies and the prediction of their clinical responses in cancers. Here, we perform deep single-cell RNA sequencing on 5,063 single T cells isolated from peripheral blood, tumor, and adjacent normal tissues from six hepatocellular carcinoma patients. The transcriptional profiles of these individual cells, coupled with assembled T cell receptor (TCR) sequences, enable us to identify 11 T cell subsets based on their molecular and functional properties and delineate their developmental trajectory. Specific subsets such as exhausted CD8+ T cells and Tregs are preferentially enriched and potentially clonally expanded in hepatocellular carcinoma (HCC), and we identified signature genes for each subset. One of the genes, layilin, is upregulated on activated CD8+ T cells and Tregs and represses the CD8+ T cell functions in vitro. This compendium of transcriptome data provides valuable insights and a rich resource for understanding the immune landscape in cancers.&lt;/p&gt;
&lt;ul class=&#34;cta-group&#34;&gt;
  
  &lt;li&gt;
    &lt;a href=&#34;https://example.com/article/&#34;  class=&#34;btn btn-primary px-3 py-3&#34;&gt;&lt;font color=&#39;white&#39;&gt; &amp;lt; Back to Articles &lt;/font&gt;&lt;/a&gt;
  &lt;/li&gt;
  
  
  &lt;li&gt;
    &lt;a href=&#34;https://example.com/&#34; &gt;
      Alternative to Homepage &lt;i class=&#34;fas fa-angle-right&#34;&gt;&lt;/i&gt;
    &lt;/a&gt;
  &lt;/li&gt;
  
&lt;/ul&gt;

</description>
    </item>
    
    <item>
      <title>Emerging Biological Principles of Metastasis</title>
      <link>https://example.com/review/28187288/</link>
      <pubDate>Thu, 09 Feb 2017 00:00:00 +0000</pubDate>
      <guid>https://example.com/review/28187288/</guid>
      <description>&lt;p&gt;&lt;strong&gt;Abstract&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Metastases account for the great majority of cancer-associated deaths, yet this complex process remains the least understood aspect of cancer biology. As the body of research concerning metastasis continues to grow at a rapid rate, the biological programs that underlie the dissemination and metastatic outgrowth of cancer cells are beginning to come into view. In this review we summarize the cellular and molecular mechanisms involved in metastasis, with a focus on carcinomas where the most is known, and we highlight the general principles of metastasis that have begun to emerge.&lt;/p&gt;
&lt;ul class=&#34;cta-group&#34;&gt;
  
  &lt;li&gt;
    &lt;a href=&#34;https://example.com/review/&#34;  class=&#34;btn btn-primary px-3 py-3&#34;&gt;&lt;font color=&#39;white&#39;&gt; &amp;lt; Back to Reviews &lt;/font&gt;&lt;/a&gt;
  &lt;/li&gt;
  
  
  &lt;li&gt;
    &lt;a href=&#34;https://example.com/&#34; &gt;
      Alternative to Homepage &lt;i class=&#34;fas fa-angle-right&#34;&gt;&lt;/i&gt;
    &lt;/a&gt;
  &lt;/li&gt;
  
&lt;/ul&gt;

</description>
    </item>
    
    <item>
      <title>Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer</title>
      <link>https://example.com/review/26544935/</link>
      <pubDate>Thu, 05 Nov 2015 00:00:00 +0000</pubDate>
      <guid>https://example.com/review/26544935/</guid>
      <description>&lt;p&gt;&lt;strong&gt;Abstract&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Two decades of studies in multiple model organisms have established the Hippo pathway as a key regulator of organ size and tissue homeostasis. By inhibiting YAP and TAZ transcription co-activators, the Hippo pathway regulates cell proliferation, apoptosis, and stemness in response to a wide range of extracellular and intracellular signals, including cell-cell contact, cell polarity, mechanical cues, ligands of G-protein-coupled receptors, and cellular energy status. Dysregulation of the Hippo pathway exerts a significant impact on cancer development. Further investigation of the functions and regulatory mechanisms of this pathway will help uncovering the mystery of organ size control and identify new targets for cancer treatment.&lt;/p&gt;
&lt;ul class=&#34;cta-group&#34;&gt;
  
  &lt;li&gt;
    &lt;a href=&#34;https://example.com/review/&#34;  class=&#34;btn btn-primary px-3 py-3&#34;&gt;&lt;font color=&#39;white&#39;&gt; &amp;lt; Back to Reviews &lt;/font&gt;&lt;/a&gt;
  &lt;/li&gt;
  
  
  &lt;li&gt;
    &lt;a href=&#34;https://example.com/&#34; &gt;
      Alternative to Homepage &lt;i class=&#34;fas fa-angle-right&#34;&gt;&lt;/i&gt;
    &lt;/a&gt;
  &lt;/li&gt;
  
&lt;/ul&gt;

</description>
    </item>
    
    <item>
      <title>Molecular pathways: autophagy in cancer--a matter of timing and context</title>
      <link>https://example.com/review/25165101/</link>
      <pubDate>Wed, 27 Aug 2014 00:00:00 +0000</pubDate>
      <guid>https://example.com/review/25165101/</guid>
      <description>&lt;p&gt;&lt;strong&gt;Abstract&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Autophagy is an intracellular self-digestion mechanism, by which cellular components are sorted into double-membrane autophagosomes and delivered to lysosomes for degradation. Cells use autophagy to dispose of wastes and eliminate hazards, while recycling nutrients and tuning metabolism in the process. Through these functions, autophagy promotes cell fitness, genome integrity, tissue homeostasis, and cell survival and growth under stress. Both autophagy upregulation and downregulation have been found in human cancers, suggesting a complex role in tumor development. Accumulating results from autophagy-deficient mice and mouse models of human cancers have demonstrated that autophagy generally suppresses tumor initiation, but promotes tumor progression, in a manner that is dependent on timing and context and modified by specific tumorigenic events. Given the role of autophagy in facilitating tumor growth, autophagy inhibition has gained wide attention as a potential anticancer therapy. Here, we summarize relevant genetic, preclinical, and clinical studies and discuss the multifaceted role of autophagy in cancer, as well as the prospects of autophagy inhibition for cancer therapy.&lt;/p&gt;
&lt;ul class=&#34;cta-group&#34;&gt;
  
  &lt;li&gt;
    &lt;a href=&#34;https://example.com/review/&#34;  class=&#34;btn btn-primary px-3 py-3&#34;&gt;&lt;font color=&#39;white&#39;&gt; &amp;lt; Back to Reviews &lt;/font&gt;&lt;/a&gt;
  &lt;/li&gt;
  
  
  &lt;li&gt;
    &lt;a href=&#34;https://example.com/&#34; &gt;
      Alternative to Homepage &lt;i class=&#34;fas fa-angle-right&#34;&gt;&lt;/i&gt;
    &lt;/a&gt;
  &lt;/li&gt;
  
&lt;/ul&gt;

</description>
    </item>
    
    <item>
      <title>Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells</title>
      <link>https://example.com/article/18355723/</link>
      <pubDate>Fri, 21 Mar 2008 00:00:00 +0000</pubDate>
      <guid>https://example.com/article/18355723/</guid>
      <description>&lt;p&gt;&lt;strong&gt;Abstract&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;We screened small molecules to identify two compounds, which we named RSL3 and RSL5, that have increased lethality in the presence of oncogenic RAS. Counter screening with biologically active compounds defined aspects of the mechanism of action for RSL3 and RSL5, such as a nonapoptotic, MEK-dependent, and iron-dependent oxidative cell death. Erastin, a previously reported compound with RAS-selective lethality, showed similar properties. RNA interference experiments targeting voltage-dependent anion channel 3 (VDAC3), a target of erastin, demonstrated that RSL5 is a scaffold that acts through VDACs to activate the observed pathway. RSL3 activated a similar death mechanism but in a VDAC-independent manner. We found that cells transformed with oncogenic RAS have increased iron content relative to their normal cell counterparts through upregulation of transferrin receptor 1 and downregulation of ferritin heavy chain 1 and ferritin light chain.&lt;/p&gt;
&lt;ul class=&#34;cta-group&#34;&gt;
  
  &lt;li&gt;
    &lt;a href=&#34;https://example.com/article/&#34;  class=&#34;btn btn-primary px-3 py-3&#34;&gt;&lt;font color=&#39;white&#39;&gt; &amp;lt; Back to Articles &lt;/font&gt;&lt;/a&gt;
  &lt;/li&gt;
  
  
  &lt;li&gt;
    &lt;a href=&#34;https://example.com/&#34; &gt;
      Alternative to Homepage &lt;i class=&#34;fas fa-angle-right&#34;&gt;&lt;/i&gt;
    &lt;/a&gt;
  &lt;/li&gt;
  
&lt;/ul&gt;

</description>
    </item>
    
  </channel>
</rss>
